Mark Crockett, MDMolecular ImagingTargeted radiopharmaceuticals offer new hope for longer 'healthspans'Precision radiopharmaceuticals accurately target tumors while minimizing damage to healthy tissue, presenting an opportunity to extend not just lifespans but “healthspans,” Mark Crockett, MD, explains in this article.March 15, 2024Page 1 of 1Top StoriesMolecular ImagingPET/CT scans show lung damage in stone workersThe metabolic activities occurring in the lungs of these patients have been unknown.CTSCCT: Study explores diagnostic accuracy of CCTACTSCCT: AI predicts coronary artery calcium scores from chest x-raysCTSCCT: CCTA model shows plaque volume changes in chest pain patientsSponsor ContentWhen time is of the essence
